Safety and Efficacy of Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- Oregon Health and Science University
- Study ID
- NCT06946576
- Phase
- PHASE3
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Congenital Diaphragmatic Hernia
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Fetoscopic Endoluminal Tracheal Occlusion (FETO) Procedure — DEVICEFETO procedure involves insertion of a balloon into the fetal trachea under IV sedation with local anesthesia or combined spinal-epidural anesthesia. Balloon removal will take place up to 7 weeks after insertion.
Study Details
The purpose of this study is to evaluate the safety and efficacy of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in cases of severe Congenital Diaphragmatic Hernia (CDH).
Key Dates
- Start date
- Sep 30, 2025
- Status verified
- Aug 2025
- Primary completion
- Apr 30, 2030
- Completion
- Apr 30, 2030
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Fetal treatment armCases that will undergo Fetoscopic Endoluminal Tracheal Occlusion (FETO) procedure.
- No Intervention: Expectant management armCases that meet study inclusion criteria but voluntarily decline the Fetoscopic Endoluminal Tracheal Occlusion (FETO) procedure. These cases will undergo the standard of clinical care.
Primary Outcome Measure
Outcomes of placement and removal of FETO device [ Time Frame: Device placement will take place between 27 weeks 0 days and 29 weeks 6 days gestation. Removal will take place between 34 weeks 0 days and 34 weeks 6 days. ]
Central Contacts
- Women's Health Research Unit Department of Ob/Gyn503-494-3666
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Oregon Health & Science University | Portland | Oregon | 97239 | - |
Find similar trials in Portland, OR
By research site
Related Studies
- Diaphragmatic Hernia Research & Exploration, Advancing Molecular ScienceRecruiting · Columbia University · Chicago, Illinois
- De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic HerniaPHASE4 · Recruiting · The University of Texas Health Science Center, Houston · Birmingham, Alabama
- Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic HerniaRecruiting · Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio
- Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)Recruiting · Rodrigo Ruano · Miami, Florida